Advertisement

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x100px
Organisation › Details

ScreenIn3D Ltd.

ScreenIn3D (Glasgow, UK) is a new joint venture company set up by AMSBIO and the University of Strathclyde exploiting the latest advances in microfluidics and 3D culture to develop a novel microfluidic screening platform. The unique combination of microfluidic lab-on-a-chip technology with physiologically relevant 3D spheroids is designed to make drug discovery more closely relevant with what happens in the body. The ability to micro size drug-cell interactions will allow pharmaceutical and biotech companies do 100x more testing for the same money spent as well as increasing productivity as it enables more experiments to be done on the same platform at the same time. OncoScreen service - the first application platform launched by ScreenIn3D is targeted at improving anticancer drug treatment and accelerating development of new personalized medicine solutions using patient-derived tissue. Chosen by the Society for Laboration Automation & Screening (SLAS Europe) as an exciting innovation technology company (presented at SLAS Europe 2018), the ONCOSCREEN service offers users the ability to reduce and replace animal models in cancer research. As well as offering 100-fold greater throughput than existing cancer screening assays for same cost – ONCOSCREEN also provides a larger screening capability of patient-derived tissue than any existing services. *

 

Period Start 2018-07-01 established jv
  Group AMSBIO (AMS Biotechnology) (Group)
Products Industry drug screening (service)
  Industry 2 OncoScreen service (microfluidic 3D culture screening platform)
Person Person Sim, Alex (AMS Biotechnology 201007)
     
Region Region Glasgow
  Country United Kingdom (GB)
  Street 99 George Street
Technology & Innovation Centre
  City G1 1RD Glasgow
  Tel +44-141-444-7368
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: AMS Biotechnology (Europe) Ltd.. (7/6/18). "Press Release: AMSBIO and University of Strathclyde Jointly Launch New Screening Company".
     
   
Record changed: 2023-07-10

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for AMSBIO (AMS Biotechnology) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x300px




» top